SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (1019)7/22/1997 5:42:00 PM
From: JOHN W.   of 6136
 
IMS DATA STRONG AGAIN.

For the week ending 11 July, scrips demonstrated nearly the entire gowth in the PI market. Crixivan continues to lose market share to Viracept.

NEW SRIPS; 2,803 UP 17% FROM 2,405 THE PREV WEEK.

TOTAL SCRIPS; 6,525 UP 19% FROM 5,504 THE PREV WEEK.

SINCE UP TO ONE THIRD OF PATIENTS OBTAIN NELF FROM NON-RETAIL CHANNELS; DIVIDE THE IMS DATA BY 0.66:

NEW SCRIPS: 4,247.

TOATAL SCRIPS: 9,886.

NEARLY 10,000 TOTAL SCRIPS FOR ONE WEEK :-)

See you at $$$$140$$$$$$, John.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext